DOCSLIB.ORG

Generative Medicine

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Generative Medicine FUNDAMENTALS OF GENERATIVE MEDICINE VOLUME I: CONCEPTS, SYSTEMS AND PATHWAYS PETER J. D’ADAMO, ND MIFHI Copyright 2010 by Peter J. D’Adamo, ND, MIFHI Printed in the United States by Drum Hill Publishing, LLC. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means without the prior written permission of the publisher. Cover art by Peter D’Adamo. Based on a cellular automaton algorithms devised by Stephen Wolfram. 213 Danbury Road, Wilton CT 06897 USA www.drumhillbooks.com ISBN 978-0-9828720-0-0 FUNDAMENTALS OF GENERATIVE MEDICINE | ii “You will seek not a near, but a distant, objective, and you will not be satisfied with what you have done. All that you may achieve or discover you will regard as a fragment of a larger pattern, which from his separate approach every true scholar is striving to descry.” Aims of the Harvard Society of Fellows (1938) FUNDAMENTALS OF GENERATIVE MEDICINE | iii FUNDAMENTALS OF GENERATIVE MEDICINE | iv TABLE OF CONTENTS THE SIMPLE, THE COMPLEX, AND THE GENERATIVE..............................................................................................................17 I. DEUS EX MACHINA ........................................................................................................................................... 23 THE GAME OF LIFE .....................................................................................................................................................................25 Complexity versus complicated ................................................................................................................................................ 27 How things happen......................................................................................................................................................................... 30 Living Systems Theory.................................................................................................................................................................. 31 Life on the edge of chaos .............................................................................................................................................................. 37 THE GREAT CHAIN OF BEING....................................................................................................................................................41 Naturphilosophie...................................................................................................................................................................45 Vitalism ................................................................................................................................................................................................ 46 Preformationism.............................................................................................................................................................................. 47 Epigenesis........................................................................................................................................................................................... 48 GEMMULES...................................................................................................................................................................................51 Pangenesis and Mendelian Inheritance.......................................................................................................................53 Darwin’s Pangenesis ...................................................................................................................................................................... 54 Medelian inheritance ..................................................................................................................................................................... 56 Lamarckism........................................................................................................................................................................................ 59 Weissman’s New Preformationism ......................................................................................................................................... 60 Wrong turns.............................................................................................................................................................................62 Eugenics............................................................................................................................................................................................... 63 Lysenkoism ........................................................................................................................................................................................ 65 Modern Times..........................................................................................................................................................................67 The Modern Synthesis................................................................................................................................................................... 67 II. VARIATION AND INHERITANCE ................................................................................................................. 69 HELLO WORLD.............................................................................................................................................................................71 What is code?...........................................................................................................................................................................72 Transcription and replication: DNA ........................................................................................................................................ 74 Translation: RNA ............................................................................................................................................................................. 78 Proteins................................................................................................................................................................................................ 83 Chromosomes ................................................................................................................................................................................... 87 Cell Cycles..................................................................................................................................................................................90 Mitosis .................................................................................................................................................................................................. 90 Meiosis.................................................................................................................................................................................................. 93 RIGHT FROM WRONG FROM RIGHT...........................................................................................................................................97 Mutations..................................................................................................................................................................................99 Transposable elements.............................................................................................................................................................. 102 Copy number variations .................................................................................................................................................. 106 Fusion genes ................................................................................................................................................................................... 107 Population Genetics........................................................................................................................................................... 110 Haplotypes and haplogroups................................................................................................................................................... 111 GENETICS AS AN INTERACTIVE SPORT ..................................................................................................................................115 What is Information?........................................................................................................................................................ 116 Cistrons and open reading frames (ORF)........................................................................................................................... 120 RNA splicing.................................................................................................................................................................................... 121 Linkage disequilibrium, pleiotropy and epistasis .......................................................................................................... 123 Pleiotropy......................................................................................................................................................................................... 126 Epistasis...........................................................................................................................................................................................
Load more

Recommended publications
  • Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse
    Welcome to More Choice CD Marker Handbook For more information, please visit: Human bdbiosciences.com/eu/go/humancdmarkers Mouse bdbiosciences.com/eu/go/mousecdmarkers Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse CD3 CD3 CD (cluster of differentiation) molecules are cell surface markers T Cell CD4 CD4 useful for the identification and characterization of leukocytes. The CD CD8 CD8 nomenclature was developed and is maintained through the HLDA (Human Leukocyte Differentiation Antigens) workshop started in 1982. CD45R/B220 CD19 CD19 The goal is to provide standardization of monoclonal antibodies to B Cell CD20 CD22 (B cell activation marker) human antigens across laboratories. To characterize or “workshop” the antibodies, multiple laboratories carry out blind analyses of antibodies. These results independently validate antibody specificity. CD11c CD11c Dendritic Cell CD123 CD123 While the CD nomenclature has been developed for use with human antigens, it is applied to corresponding mouse antigens as well as antigens from other species. However, the mouse and other species NK Cell CD56 CD335 (NKp46) antibodies are not tested by HLDA. Human CD markers were reviewed by the HLDA. New CD markers Stem Cell/ CD34 CD34 were established at the HLDA9 meeting held in Barcelona in 2010. For Precursor hematopoetic stem cell only hematopoetic stem cell only additional information and CD markers please visit www.hcdm.org. Macrophage/ CD14 CD11b/ Mac-1 Monocyte CD33 Ly-71 (F4/80) CD66b Granulocyte CD66b Gr-1/Ly6G Ly6C CD41 CD41 CD61 (Integrin b3) CD61 Platelet CD9 CD62 CD62P (activated platelets) CD235a CD235a Erythrocyte Ter-119 CD146 MECA-32 CD106 CD146 Endothelial Cell CD31 CD62E (activated endothelial cells) Epithelial Cell CD236 CD326 (EPCAM1) For Research Use Only.
    [Show full text]
  • Mcleod Neuroacanthocytosis Syndrome
    NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health. Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993- 2017. McLeod Neuroacanthocytosis Syndrome Hans H Jung, MD Department of Neurology University Hospital Zurich Zurich, Switzerland [email protected] Adrian Danek, MD Neurologische Klinik Ludwig-Maximilians-Universität München, Germany ed.uml@kenad Ruth H Walker, MD, MBBS, PhD Department of Neurology Veterans Affairs Medical Center Bronx, New York [email protected] Beat M Frey, MD Blood Transfusion Service Swiss Red Cross Schlieren/Zürich, Switzerland [email protected] Christoph Gassner, PhD Blood Transfusion Service Swiss Red Cross Schlieren/Zürich, Switzerland [email protected] Initial Posting: December 3, 2004; Last Update: May 17, 2012. Summary Clinical characteristics. McLeod neuroacanthocytosis syndrome (designated as MLS throughout this review) is a multisystem disorder with central nervous system (CNS), neuromuscular, and hematologic manifestations in males. CNS manifestations are a neurodegenerative basal ganglia disease including (1) movement disorders, (2) cognitive alterations, and (3) psychiatric symptoms. Neuromuscular manifestations include a (mostly subclinical) sensorimotor axonopathy and muscle weakness or atrophy of different degrees. Hematologically, MLS is defined as a specific blood group phenotype (named after the first proband, Hugh McLeod) that results from absent expression of the Kx erythrocyte antigen and weakened expression of Kell blood group antigens. The hematologic manifestations are red blood cell acanthocytosis and compensated hemolysis. Allo-antibodies in the Kell and Kx blood group system can cause strong reactions to transfusions of incompatible blood and severe anemia in newborns of Kell-negative mothers.
    [Show full text]
  • GLYCO 21 XXI International Symposium on Glycoconjugates
    GLYCO 21 XXI International Symposium on Glycoconjugates Abstracts August 21-26, 2011 Vienna, Austria Glycoconj J (2011) 28: 197–36 9 Organising Committee Erika Staudacher (Austria) Leopold März (Austria) Günter Allmaier (Austria) Lothar Brecker (Austria) Josef Glössl (Austria) Hanspeter Kählig (Austria) Paul Kosma (Austria) Lukas Mach (Austria) Paul Messner (Austria) Walther Schmid (Austria) Igor Tvaroška (Slovakia) Reinhard Vlasak (Austria) Iain Wilson (Austria) Scientifi c Program Committee Iain Wilson (Austria) Paul Messner (Austria) Günter Allmaier (Austria) Reginald Bittner (Austria) Paul Kosma (Austria) Eva Stöger (Austria) Graham Warren (Austria) John Hanover (USA; nominated by the Society for Glycobiology) Kelly ten Hagen (USA; nominated by the Society for Glycobiology) supported in abstract selection by Michael Duchêne (Austria) Catherine Merry (UK) Tadashi Suzuki (Japan) Abstracts of the 21st International Symposium on Glycoconjugates The International Glycoconjugate Organisation Gerald W. Hart, President Leopold März, President-elect Paul Gleeson, Immediate Past-president Sandro Sonnino, Secretary Thierry Hennet, Treasurer National Representatives Pedro Bonay (Spain) to replace Angelo Reglero Nicolai Bovin (Russia) Jin Won Cho (Korea) Henrik Clausen (Denmark) Anne Dell (UK) Jukka Finne (Finland) Paul Gleeson (Australia) Jianxin Gu (China) Gerald Hart (USA) Thierry Hennet (Switzerland) Jim Jamieson (Canada) Gordan Lauc (Croatia) Hakon Leffl er (Sweden) Jean-Claude Michalski (France) Werner Reutter (Germany) Sandro Sonnino (Italy) Avadhesha Surolia (India) Ken Kitajima (Japan) Maciej Ugorski (Poland) Johannes F.G. Vliegenthart (The Netherlands) Iain Wilson (Austria) to replace Leopold März Albert M. Wu (Taiwan) Lode Wyns (Belgium) Yehiel Zick (Israel) Glycoconj J (2011) 28: 197–369 Past Presidents Eugene. A. Davidson (USA) Alan B. Foster (UK) Paul Gleeson (Australia) Mary Catherine Glick (USA) Colin Hughes (UK) Roger W.
    [Show full text]
  • Immuno 2014 No. 1
    Journal of Blood Group Serology and Molecular Genetics VOLUME 30, N UMBER 1, 2014 Immunohematology Journal of Blood Group Serology and Molecular Genetics Volume 30, Number 1, 2014 CONTENTS R EPORT 1 Indirect antiglobulin test-crossmatch using low-ionic-strength saline–albumin enhancement medium and reduced incubation time: effectiveness in the detection of most clinically significant antibodies and impact on blood utilization C.L. Dinardo, S.L. Bonifácio, and A. Mendrone, Jr. R EV I EW 6 Raph blood group system M. Hayes R EPORT 11 I-int phenotype among three individuals of a Parsi community from Mumbai, India S.R. Joshi C A SE R EPORT 14 Evans syndrome in a pediatric liver transplant recipient with an autoantibody with apparent specificity for the KEL4 (Kpb) antigen S.A. Koepsell, K. Burright-Hittner, and J.D. Landmark R EV I EW 18 JMH blood group system: a review S.T. Johnson R EPORT 24 Demonstration of IgG subclass (IgG1 and IgG3) in patients with positive direct antiglobulin tests A. Singh, A. Solanki, and R. Chaudhary I N M EMOR ia M 28 George Garratty, 1935–2014 Patricia A. Arndt and Regina M. Leger 30 A NNOUNCEMENTS 34 A DVERT I SEMENTS 39 I NSTRUCT I ONS FOR A UTHORS E D I TOR - I N -C H I EF E D I TOR ia L B OA RD Sandra Nance, MS, MT(ASCP)SBB Philadelphia, Pennsylvania Patricia Arndt, MT(ASCP)SBB Paul M. Ness, MD Pomona, California Baltimore, Maryland M A N AG I NG E D I TOR James P.
    [Show full text]
  • Food Microbiology Characterization of Plant Lectins for Their Ability To
    Food Microbiology 82 (2019) 231–239 Contents lists available at ScienceDirect Food Microbiology journal homepage: www.elsevier.com/locate/fm Characterization of plant lectins for their ability to isolate Mycobacterium T avium subsp. paratuberculosis from milk Bernhard F. Hobmaiera, Karina Lutterberga, Kristina J.H. Kleinworta, Ricarda Mayerb, Sieglinde Hirmera, Barbara Amanna, Christina Hölzelb,c, Erwin P. Märtlbauerb, ∗ Cornelia A. Deega, a Chair of Animal Physiology, Department of Veterinary Sciences, LMU Munich, Veterinärstraße 13, D-80539, Munich, Germany b Chair of Hygiene and Technology of Milk, Department of Veterinary Sciences, LMU Munich, Schönleutnerstr 8, D-85764, Oberschleißheim, Germany c Institute of Animal Breeding and Husbandry, Faculty of Agricultural and Nutritional Sciences, CAU Kiel, Hermann-Rodewald-Str. 6, 24098 Kiel, Germany 1. Introduction combined with PCR (phage-PCR). The zoonotic potential of MAP is still under discussion (Kuenstner et al., 2017). It could potentially play a Mycobacterium avium subsp. paratuberculosis is the causative agent of role in inflammatory bowel diseases, like Crohn's disease and ulcerative paratuberculosis or Johne's disease, a chronic granulomatous enteritis colitis (Timms et al., 2016). Additionally, MAP infections could be in- in cattle and small ruminants, causing emaciation, decreased milk volved in the pathogenesis of autoimmune diseases like type 1 diabetes, production and, in cattle, severe diarrhea (Arsenault et al., 2014). After multiple sclerosis, rheumatoid arthritis and Hashimoto's thyroiditis infection, ruminants go through a long, asymptomatic subclinical (Garvey, 2018; Waddell et al., 2015). Although the causal link between phase, in which they cannot reliably be determined by standard diag- MAP and these diseases is not proven, the possible association ne- nostic tests (Li et al., 2017).
    [Show full text]
  • Banlec-Egfp Chimera As a Tool for Evaluation of Lectin Binding to High-Mannose Glycans on Microorganisms
    biomolecules Article BanLec-eGFP Chimera as a Tool for Evaluation of Lectin Binding to High-Mannose Glycans on Microorganisms Zorana Lopandi´c 1 , Luka Dragaˇcevi´c 2, Dragan Popovi´c 3 , Uros Andjelkovi´c 3,4, Rajna Mini´c 2 and Marija Gavrovi´c-Jankulovi´c 1,* 1 Department of Biochemistry, Faculty of Chemistry, University of Belgrade, 11000 Belgrade, Serbia; [email protected] 2 Institute of Virology, Vaccines and Sera, 11152 Belgrade, Serbia; [email protected] (L.D.); [email protected] (R.M.) 3 Institute of Chemistry, Technology and Metallurgy, National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia; [email protected] (D.P.); [email protected] (U.A.) 4 Department of Biotechnology, University of Rijeka, 5100 Rijeka, Croatia * Correspondence: [email protected]; Tel.: +381-11-3336-661 Abstract: Fluorescently labeled lectins are useful tools for in vivo and in vitro studies of the structure and function of tissues and various pathogens such as viruses, bacteria, and fungi. For the evaluation of high-mannose glycans present on various glycoproteins, a three-dimensional (3D) model of the chimera was designed from the crystal structures of recombinant banana lectin (BanLec, Protein Data Bank entry (PDB): 5EXG) and an enhanced green fluorescent protein (eGFP, PDB 4EUL) by applying molecular modeling and molecular mechanics and expressed in Escherichia coli. BanLec- eGFP, produced as a soluble cytosolic protein of about 42 kDa, revealed β-sheets (41%) as the Citation: Lopandi´c,Z.; Dragaˇcevi´c, predominant secondary structures, with the emission peak maximum detected at 509 nm (excitation L.; Popovi´c,D.; Andjelkovi´c,U.; wavelength 488 nm).
    [Show full text]
  • 3407 M16141436 19 3.Pdf
    Immunohematology JOURNAL OF BLOOD GROUP SEROLOGY AND EDUCATION V OLUME 19, NUMBER 3, 2003 Immunohematology JOURNAL OF BLOOD GROUP SEROLOGY AND EDUCATION V OLUME 19, NUMBER 3, 2003 CONTENTS 73 DNA analysis for donor screening of Dombrock blood group antigens J.R. STORRY, C.M.WESTHOFF,D.CHARLES-PIERRE,M.RIOS,K.HUE-ROYE,S.VEGE,S.NANCE, AND M.E. REID 77 Studies on the Dombrock blood group system in non-human primates C. MOGOS,A.SCHAWALDER,G.R. HALVERSON, AND M.E. REID 83 Murine monoclonal antibodies can be used to type RBCs with a positive DAT G.R. HALVERSON,P.HOWARD,H.MALYSKA,E.TOSSAS, AND M.E. REID 86 Rh antigen and phenotype frequencies and probable genotypes for the four main ethnic groups in Port Harcourt, Nigeria Z.A. JEREMIAH AND F.I. BUSERI 89 Antibodies detected in samples from 21,730 pregnant women S. JOVANOVIC-SRZENTIC,M.DJOKIC,N.TIJANIC,R.DJORDJEVIC,N.RIZVAN,D.PLECAS, AND D. FILIMONOVIC 93 BOOK REVIEWS S. GERALD SANDLER,MD THERESA NESTER,MD 95 COMMUNICATIONS Letter to the Editors Letter From the Editors Irregular RBC antibodies in the Ortho Dedication sera of Brazilian pregnant women 97 IN MEMORIAM BERTIL CEDEGREN,MD 98 99 ANNOUNCEMENTS ADVERTISEMENTS 103 INSTRUCTIONS FOR AUTHORS EDITOR-IN-CHIEF MANAGING EDITOR Delores Mallory, MT(ASCP)SBB Mary H. McGinniss,AB, (ASCP)SBB Rockville, Maryland Bethesda, Maryland TECHNICAL EDITOR SENIOR MEDICAL EDITOR Christine Lomas-Francis, MSc Scott Murphy, MD New York, New York Philadelphia, Pennsylvania ASSOCIATE MEDICAL EDITORS S. Gerald Sandler, MD Geralyn Meny, MD Ralph Vassallo, MD Washington, District of Columbia Philadelphia, Pennsylvania Philadelphia, Pennsylvania EDITORIAL BOARD Patricia Arndt, MT(ASCP)SBB W.
    [Show full text]
  • Raybiotech Lectin Array 70 --Detect Glycan Profiles Using 70 Lectins
    RayBiotech Lectin Array 70 --Detect glycan profiles using 70 lectins User Manual (Version 2) August 20, 2018 Cat # GA-Lectin-70 RayBiotech, Inc. We Provide You With Excellent Protein Array Systems and Service Tel:(Toll Free) 1-888-494-8555 or 770-729-2992; Fax: 770-206-2393; Website:www.RayBiotech.com Email: [email protected] AAA, AAL, ACG, ACL, ASA, BanLec, BC2L-A, BC2LCN, BPA, Calsepa, CGL2, CNL, Con A, DBA, Discoidin I, Discoidin II, DSA, ECA, EEL, F17AG, Gal1, Gal1-S, Gal2, Gal3, Gal3C-S, Lectins printed on Gal7-S, Gal9, GNA, GRFT, GS-I, GS-II, HHA, Jacalin, LBA, LCA, slides (70) LEA, Lentil, Lotus, LSL-N, MAA, Malectin, MOA, MPL, NPA, Orysata, PA-IIL, PA-IL, PALa, PHA-E, PHA-L, PHA-P, PNA, PPL, PSA, PSL1a, PTL, RS-Fuc, SAMB, SBA, SJA, SNA-I, SNA-II, STL, UDA, UEA-I, UEA-II, VFA, VVA, WFA, WGA One standard glass slide is spotted with 14 wells of Format identical lectin sub-arrays. Each lectin is printed in duplicate on every sub-array Detection Method Fluorescence with laser scanner: Cy3 equivalent dye Sample Volume 50 – 100 l per array Reproducibility CV <20% Assay duration 6 hrs 1 RayBiotech Lectin Array 70 Kit TABLE OF CONTENTS I. Overview………………………………………………………………………………………………………………………………..………………….… 1 Introduction…................................................................................................................................................ 3 How It Works………………………………………………………………………………………………………………………………………... 4 II. Materials Provided……………………………………………………………………………………………….………………..…….. 5 III. General Considerations………………………………………………………………………………………………….….…… 6 A. Label-Based vs. Sandwich-Based Method…………………………………………… 6 B. Preparation of Samples……………………………………………………………………………………………….… 6 C. Handling Glass Slides…………………………………………………………………………………………..……….……. 7 D. Incubation…………………………………………………………………………………………………………………………………….…… 7 IV. Protocol……………………………………………………………………………………………………………………………………………………….… 8 A. Dialysis of Sample…………………………………………………….……………………………………………………………. 8 B. Biotin-labeling Sample………………………………………………………….…………………………………………. 9 C.
    [Show full text]
  • Lectins and Glycobiology State of the Art Labeling & Detection Systems
    LECTINS AND GLYCOBIOLOGY STATE OF THE ART LABELING & DETECTION SYSTEMS Vector Laboratories Inc., USA Vector Laboratories Ltd., UK Vector Laboratories, Inc., Canada 30 Ingold Road 3 Accent Park, Bakewell Road 3390 South Service Road Burlingame, CA 94010 Orton Southgate, Peterborough PE2 6XS Burlington, Ontario L7N 3J5 (800) 227-6666 (orders) (01733) 237999 (telephone) (888) 629-2121 (orders only) (650) 697-3600 (technical service) (01733) 237119 (fax) (905) 681-0900 (tel) (650) 697-0339 (fax) [email protected] (email) (905) 681-0166 (fax) [email protected] (email) www.vectorlabs.com [email protected] (email) www.vectorlabs.com www.vectorlabs.com Introduction Since the 1880’s, it has been known that extracts from certain plants could agglutinate red blood cells. In the 1940’s, agglutinins were discovered which could “select” types of cells based on their blood group activities. Although “lectin” was originally coined to define agglutinins that could discriminate among types of red blood cells, today the term is used more generally and includes sugar-binding proteins from many sources regardless of their ability to agglutinate cells. Lectins have been found in plants, viruses, microorganisms, and animals but despite their ubiquity, in many cases their biological function is unclear. Most lectins are multimeric, consisting of non-covalently associated subunits. It is this multimeric structure that gives lectins their ability to agglutinate cells or form precipitates with glycoconjugates in a manner similar to antigen-antibody interactions. This unique group of proteins has provided researchers with powerful tools to explore a myriad of biological structures and processes. Because of the specificity that each lectin has toward a particular carbohydrate structure, even oligosaccharides with identical sugar compositions can be distinguished or separated.
    [Show full text]
  • ABO, Rh and Kell) and Ncovid-19 Susceptibility – a Retrospective Observational Study
    Relationship between blood group phenotypes (ABO, Rh and Kell) and nCOVID-19 susceptibility – A retrospective observational study. Sudhir Bhandari SMS Medical College and Hospitals, Jaipur, Rajasthan, India Ajeet Singh Shaktawat SMS Medical College and Hospitals, Jaipur, Rajasthan, India Amit Tak ( [email protected] ) SMS Medical College and Hospitals, Jaipur, Rajasthan, India https://orcid.org/0000-0003-2509-2311 Bhoopendra Patel Government Medical College, Barmer, Rajasthan, India Jyotsna Shukla SMS Medical College and Hospitals, Jaipur, Rajasthan, India Sanjay Singhal SMS Medical College and Hospitals, Jaipur, Rajasthan, India Kapil Gupta SMS Medical College and Hospitals, Jaipur, Rajasthan, India Jitendra Gupta SMS Medical College and Hospitals, Jaipur, Rajasthan, India Shivankan Kakkar SMS Medical College and Hospitals, Jaipur, Rajasthan, India Amitabh Dube SMS Medical College and Hospitals, Jaipur, Rajasthan, India Sunita Dia Medstar Washington Hospital Center, Washington DC 20010, USA. Mahendra Dia North Carolina State University, Raleigh, NC 27695-7609, USA. Todd C Wehner North Carolina State University, Raleigh, NC 27695-7609, USA. Research Article Keywords: ABO blood grouping, coronavirus disease, COVID-19, multinomial test Page 1/13 Posted Date: July 10th, 2020 DOI: https://doi.org/10.21203/rs.3.rs-39611/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 2/13 Abstract Since the outbreak of coronavirus disease-19 research has been continued to explore multiple facets of the disease. The objective of the present study is to evaluate the relationship between blood group phenotypes and COVID-19 susceptibility. In this hospital based, retrospective observational study 132 COVID-19 patients were enrolled from SMS Medical College and attached Hospitals, Jaipur, India after the proper approval from the institutional ethics committee.
    [Show full text]
  • Banana Lectin from Musa Paradisiaca Is Mitogenic for Cow and Pig PBMC Via IL-2 Pathway and ELF1
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 2 August 2021 Article Banana lectin from Musa paradisiaca is mitogenic for cow and pig PBMC via IL-2 pathway and ELF1 Roxane L. Degroote 1, Lucia Korbonits 1, Franziska Stetter 1, Kristina J. H. Kleinwort 1, Marie-Christin Schilloks 1, Barbara Amann 1, Sieglinde Hirmer 1, Stefanie M. Hauck 2 and Cornelia A. Deeg 1 * 1 Chair of Animal Physiology, Department of Veterinary Sciences, LMU Munich, D-82152 Martinsried, Germany; [email protected] (R.D.); [email protected] (L.K.); [email protected] (F.S.); [email protected] (K.K.); [email protected] (M.S.); [email protected] (B.A.); [email protected] (S.H.) 2 Research Unit Protein Science, Helmholtz Center Munich, German Research Center for Environmental Health, D-80939 Munich, Germany; [email protected] * Correspondence: [email protected] 1 Abstract: The aim of the study was to gain deeper insights in the potential for polyclonal stimulation of PBMC from cows and pigs with banana lectin (BanLec) from Musa paradisiaca. BanLec induced a marked proliferative response in cow and pig PBMC. The response in pigs was even higher than to Concanavalin A. Molecular processes associated with respective responses were examined with differential proteome analyses. Discovery proteomic experiments was applied to BanLec stimulated PBMC and cellular and secretome responses were analyzed with label free LC-MS/MS. In PBMC, 3955 proteins were identified. After polyclonal stimulation with BanLec, 459 proteins showed significantly changed abundance in PBMC.
    [Show full text]
  • Inclusion of Additional Reference Reagents in the Existing Collection of WHO International Reference Reagents for Blood Group Genotyping
    WHO/BS/2019.2371 ENGLISH ONLY EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION Geneva, 21 to 25 October 2019 Inclusion of Additional Reference Reagents in the Existing Collection of WHO International Reference Reagents for Blood Group Genotyping Report of the international collaborative study to evaluate eighteen additional candidates for addition to the existing collection of four WHO International Reference Reagents for blood group genotyping Evgeniya Volkova1, Emilia Sippert1, Meihong Liu1, Teresita Mercado1, Gregory A Denomme2, Orieji Illoh1, Zhugong Liu1, Maria Rios1*, and the Collaborative Study Group3 1 Office of Blood Research and Review, CBER/FDA, Silver Spring, MD, USA. 2 Blood Research Institute and Diagnostic Laboratories, Versiti/BloodCenter of Wisconsin, Milwaukee, WI, USA. * Principal contact: [email protected] 3 Members of the Collaborative Study Group are listed in Appendix 1. NOTE: This document has been prepared for the purpose of inviting comments and suggestions on the proposals contained therein, which will then be considered by the Expert Committee on Biological Standardization (ECBS). Comments MUST be received by 27 September 2019 and should be addressed to the World Health Organization, 1211 Geneva 27, Switzerland, attention: Technologies, Standards and Norms (TSN). Comments may also be submitted electronically to the Responsible Officer: Dr Ivana Knezevic at email: [email protected]. © World Health Organization 2019 All rights reserved. This draft is intended for a restricted audience only, i.e. the individuals and organizations having received this draft. The draft may not be reviewed, abstracted, quoted, reproduced, transmitted, distributed, translated or adapted, in part or in whole, in any form or by any means outside these individuals and organizations (including the organizations' concerned staff and member organizations) without the permission of the World Health Organization.
    [Show full text]